BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 114.13 USD 0.55% Market Closed
Market Cap: 27.5B USD
Have any thoughts about
BioNTech SE?
Write Note

BioNTech SE
Investor Relations

BioNTech SE, founded in 2008 by the visionary duo Ugur Sahin and Özlem Türeci, has gradually emerged as a shining beacon in the world of biotechnology. Situated in Mainz, Germany, BioNTech carved its niche by focusing on the development of personalized therapies for cancer and other serious diseases. The company’s core competence lies in utilizing messenger RNA (mRNA) technology, which allows it to instruct the body to produce proteins that can stimulate an immune response. This technology became a game changer, not only in the cancer arena but also expanded its reach into infectious diseases, showcasing a broader horizon of possibilities. BioNTech’s ability to leverage its research expertise in mRNA placed it at the forefront of scientific innovation, demonstrating breathtaking adaptability and ingenuity.

The company's business model thrives on strategic partnerships and collaborations, which bolster both its scientific output and financial standing. One of its most celebrated partnerships is with Pfizer, a collaboration that led to the development of the groundbreaking COVID-19 vaccine, Comirnaty. This collaboration thrust BioNTech onto the global stage, underscoring its capacity to swiftly respond to urgent health crises while generating substantial revenue. The success and distribution of the vaccine not only provided a significant boost to BioNTech’s financials but also validated its platform as powerful and versatile. By continually investing in research and development, both independently and through alliances, BioNTech aims to solidify its position as a leader in the evolving biotech landscape, paving the way for future therapies that could redefine medical treatments.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Ugur Sahin M.D.
Co-Founder, CEO & Chair of the Management Board
No Bio Available
Dr. Ozlem Tureci M.D.
Co-Founder, Chief Medical Officer & Member of Management Board
No Bio Available
Mr. Jens H. Holstein
CFO & Member of Management Board
No Bio Available
Dr. Sierk Poetting Ph.D.
MD, COO & Member of Management Board
No Bio Available
Mr. Ryan Richardson
Chief Strategy Officer, MD & Member of Management Board
No Bio Available
Dr. James Timothy Patrick Ryan Ph.D.
Chief Legal & Business Officer & Member of the Management Board
No Bio Available
Mr. Sean Marett
Executive Officer
No Bio Available
Ms. Lisa Birringer
Senior Vice President of Global Financial Reporting & Accounting
No Bio Available
Mr. Zach Taylor
Senior Vice President of Corporate Development & Strategy
No Bio Available
Dr. Katalin Kariko Ph.D.
Senior VP & External Consultant for RNA Protein Replacement Therapies
No Bio Available

Contacts

Address
RHEINLAND-PFALZ
Mainz
An der Goldgrube 12
Contacts
+4949613190840.0
biontech.de